Mackenzie Financial’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,859
Closed -$424K 1565
2025
Q4
$424K Sell
12,859
-3,916
-23% -$168K ﹤0.01% 1267
2025
Q3
$951K Sell
16,775
-1,639
-9% -$84K ﹤0.01% 1080
2025
Q2
$918K Sell
18,414
-7,799
-30% -$352K ﹤0.01% 1033
2025
Q1
$775K Sell
26,213
-2,883
-10% -$107K ﹤0.01% 1051
2024
Q4
$704K Buy
29,096
+8,977
+45% +$222K ﹤0.01% 1038
2024
Q3
$371K Sell
20,119
-2,565
-11% -$45.9K ﹤0.01% 1101
2024
Q2
$458K Sell
22,684
-650
-3% -$10.8K ﹤0.01% 1040
2024
Q1
$361K Sell
23,334
-25,997
-53% -$293K ﹤0.01% 1107
2023
Q4
$439K Sell
49,331
-1,912
-4% -$14.1K ﹤0.01% 1035
2023
Q3
$318K Buy
51,243
+39,962
+354% +$297K ﹤0.01% 1121
2023
Q2
$103K Buy
+11,281
New +$112K ﹤0.01% 1409

Other funds holding HIMS

Mackenzie Financial's HIMS Position: Q1 2026 in Review

Mackenzie Financial sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 12,859 shares — an estimated $424K sold.

Mackenzie Financial first reported a position in HIMS in Q2 2023 and held it in 11 quarters. The position peaked at $951K in Q3 2025. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Mackenzie Financial reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 12,859 Hims & Hers Health shares in Q1 2026, an estimated $424K.
  • Mackenzie Financial first reported a position in Hims & Hers Health in Q2 2023 and held it in 11 quarters.
  • Mackenzie Financial's Hims & Hers Health position peaked at $951K in Q3 2025.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.